Aminoglycosides: Difference between revisions
Ostermayer (talk | contribs) |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 8: | Line 8: | ||
*Nephro and oto toxic. Risk of neuromuscular blockade. | *Nephro and oto toxic. Risk of neuromuscular blockade. | ||
*Can precipitate crisis in patients with [[myasthenia gravis]] | *Can precipitate crisis in patients with [[myasthenia gravis]] | ||
* Include [[gentamicin]] and [[tobramycin]] | *Include [[gentamicin]] and [[tobramycin]] | ||
==List of Aminoglycosides== | |||
{{#ask:[[Is DrugClass::Aminoglycoside]] |format=ul }} | |||
==See Also== | ==See Also== | ||
| Line 15: | Line 18: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
{{Template:Clinically Utilized Antibiotics}} | {{Template:Clinically Utilized Antibiotics}} | ||
Latest revision as of 12:42, 30 August 2025
Background
- Used (alone or with beta-lactam) to treat serious infections due to gram-negative bacilli, e.g.:
- Ill patient with pyelonephritis
- Meningitis (due to pseudomonas, acinetobacter)
- Peritoneal dialysis-associated peritonitis
- Bacterial endocarditis
- Used +/- beta-lactam
- Nephro and oto toxic. Risk of neuromuscular blockade.
- Can precipitate crisis in patients with myasthenia gravis
- Include gentamicin and tobramycin
List of Aminoglycosides
See Also
References
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||